Atlas Trials

Catalyst Biosciences

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Catalyst Biosciences

RecordFirmDate
A Natural History Study to Assess the Clinical Outcomes of Patients With Complement Factor I Deficiency-Mediated Disease (NCT05095623)Catalyst Biosciences2021-08-31
Screening Study to Identify Patients With Complement Factor I Deficiencies (NCT05072912)Catalyst Biosciences2021-07-21
Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding Disorders (NCT04548791)Catalyst Biosciences2021-05-17
Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Hemophilia A or B (NCT04489537)Catalyst Biosciences2021-05-04
Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia (NCT04072237)Catalyst Biosciences2019-09-24
Study of Next-Generation Recombinant Factor IX Variant in Adult Subjects With Hemophilia B (NCT03995784)Catalyst Biosciences2019-06-18
Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and B (NCT03407651)Catalyst Biosciences2017-12-18

Track Catalyst Biosciences automatically

Every clearance here is in the API, with alerts when new ones post.